Maven Income and Growth VCT 4 (MAV4) Competitors

GBX 48.50 0.00 (0.00%)

As of 09/14/2026

MAV4 vs. BCI, BPET, BRFI, SMIF, and BIOG

Should you buy Maven Income and Growth VCT 4 stock or one of its competitors? Maven Income and Growth VCT 4's main competitors and comparable companies include BMO Capital and Income Investment Trust (BCI), BMO Private Equity Trust (BPET), BlackRock Frontiers (BRFI), TwentyFour Select Monthly Income Fund (SMIF), and The Biotech Growth Trust (BIOG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Maven Income and Growth VCT 4 compare to BMO Capital and Income Investment Trust?

BMO Capital and Income Investment Trust (LON:BCI) and Maven Income and Growth VCT 4 (LON:MAV4) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

Maven Income and Growth VCT 4 has lower revenue, but higher earnings than BMO Capital and Income Investment Trust. Maven Income and Growth VCT 4 is trading at a lower price-to-earnings ratio than BMO Capital and Income Investment Trust, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BMO Capital and Income Investment Trust	£29.78M	0.00	N/A	£0.25	N/A
Maven Income and Growth VCT 4	-£111K	-727.01	£1.33M	-£0.34	N/A

In the previous week, Maven Income and Growth VCT 4 had 1 more articles in the media than BMO Capital and Income Investment Trust. MarketBeat recorded 1 mentions for Maven Income and Growth VCT 4 and 0 mentions for BMO Capital and Income Investment Trust. Maven Income and Growth VCT 4's average media sentiment score of 0.90 beat BMO Capital and Income Investment Trust's score of 0.00 indicating that Maven Income and Growth VCT 4 is being referred to more favorably in the news media.

Company	Overall Sentiment
BMO Capital and Income Investment Trust	Neutral
Maven Income and Growth VCT 4	Positive

BMO Capital and Income Investment Trust pays an annual dividend of GBX 0.12 per share. Maven Income and Growth VCT 4 pays an annual dividend of GBX 4.35 per share and has a dividend yield of 9.0%. BMO Capital and Income Investment Trust pays out 46.4% of its earnings in the form of a dividend. Maven Income and Growth VCT 4 pays out -1,279.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Maven Income and Growth VCT 4 is clearly the better dividend stock, given its higher yield and lower payout ratio.

Maven Income and Growth VCT 4 has a net margin of 13.78% compared to BMO Capital and Income Investment Trust's net margin of 0.00%. BMO Capital and Income Investment Trust's return on equity of 0.00% beat Maven Income and Growth VCT 4's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BMO Capital and Income Investment Trust	N/A	N/A	N/A
Maven Income and Growth VCT 4	13.78%	-0.84%	-0.11%

Summary

BMO Capital and Income Investment Trust and Maven Income and Growth VCT 4 tied by winning 5 of the 10 factors compared between the two stocks.

How does Maven Income and Growth VCT 4 compare to BMO Private Equity Trust?

BMO Private Equity Trust (LON:BPET) and Maven Income and Growth VCT 4 (LON:MAV4) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Maven Income and Growth VCT 4 has a net margin of 13.78% compared to BMO Private Equity Trust's net margin of 0.00%. BMO Private Equity Trust's return on equity of 0.00% beat Maven Income and Growth VCT 4's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BMO Private Equity Trust	N/A	N/A	N/A
Maven Income and Growth VCT 4	13.78%	-0.84%	-0.11%

BMO Private Equity Trust pays an annual dividend of GBX 0.24 per share. Maven Income and Growth VCT 4 pays an annual dividend of GBX 4.35 per share and has a dividend yield of 9.0%. BMO Private Equity Trust pays out 13.8% of its earnings in the form of a dividend. Maven Income and Growth VCT 4 pays out -1,279.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Maven Income and Growth VCT 4 is clearly the better dividend stock, given its higher yield and lower payout ratio.

Maven Income and Growth VCT 4 has lower revenue, but higher earnings than BMO Private Equity Trust. Maven Income and Growth VCT 4 is trading at a lower price-to-earnings ratio than BMO Private Equity Trust, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BMO Private Equity Trust	£147.54M	0.00	N/A	£1.76	N/A
Maven Income and Growth VCT 4	-£111K	-727.01	£1.33M	-£0.34	N/A

In the previous week, Maven Income and Growth VCT 4 had 1 more articles in the media than BMO Private Equity Trust. MarketBeat recorded 1 mentions for Maven Income and Growth VCT 4 and 0 mentions for BMO Private Equity Trust. Maven Income and Growth VCT 4's average media sentiment score of 0.90 beat BMO Private Equity Trust's score of 0.00 indicating that Maven Income and Growth VCT 4 is being referred to more favorably in the news media.

Company	Overall Sentiment
BMO Private Equity Trust	Neutral
Maven Income and Growth VCT 4	Positive

Summary

BMO Private Equity Trust and Maven Income and Growth VCT 4 tied by winning 5 of the 10 factors compared between the two stocks.

How does Maven Income and Growth VCT 4 compare to BlackRock Frontiers?

Maven Income and Growth VCT 4 (LON:MAV4) and BlackRock Frontiers (LON:BRFI) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

6.9% of BlackRock Frontiers shares are held by institutional investors. 1.8% of Maven Income and Growth VCT 4 shares are held by insiders. Comparatively, 0.5% of BlackRock Frontiers shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Maven Income and Growth VCT 4 has a beta of 0.04891589, indicating that its stock price is 95% less volatile than the broader market. Comparatively, BlackRock Frontiers has a beta of 0.852, indicating that its stock price is 15% less volatile than the broader market.

In the previous week, Maven Income and Growth VCT 4 had 1 more articles in the media than BlackRock Frontiers. MarketBeat recorded 1 mentions for Maven Income and Growth VCT 4 and 0 mentions for BlackRock Frontiers. Maven Income and Growth VCT 4's average media sentiment score of 0.90 beat BlackRock Frontiers' score of 0.00 indicating that Maven Income and Growth VCT 4 is being referred to more favorably in the media.

Company	Overall Sentiment
Maven Income and Growth VCT 4	Positive
BlackRock Frontiers	Neutral

Maven Income and Growth VCT 4 pays an annual dividend of GBX 4.35 per share and has a dividend yield of 9.0%. BlackRock Frontiers pays an annual dividend of GBX 10.01 per share and has a dividend yield of 5.2%. Maven Income and Growth VCT 4 pays out -1,279.4% of its earnings in the form of a dividend. BlackRock Frontiers pays out 24.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Maven Income and Growth VCT 4 is clearly the better dividend stock, given its higher yield and lower payout ratio.

BlackRock Frontiers has a net margin of 284.82% compared to Maven Income and Growth VCT 4's net margin of 13.78%. BlackRock Frontiers' return on equity of 15.49% beat Maven Income and Growth VCT 4's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Maven Income and Growth VCT 4	13.78%	-0.84%	-0.11%
BlackRock Frontiers	284.82%	15.49%	13.46%

BlackRock Frontiers has higher revenue and earnings than Maven Income and Growth VCT 4. Maven Income and Growth VCT 4 is trading at a lower price-to-earnings ratio than BlackRock Frontiers, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Maven Income and Growth VCT 4	-£111K	-727.01	£1.33M	-£0.34	N/A
BlackRock Frontiers	£81.92M	3.87	£73.42M	£41.78	4.60

Summary

BlackRock Frontiers beats Maven Income and Growth VCT 4 on 10 of the 15 factors compared between the two stocks.

How does Maven Income and Growth VCT 4 compare to TwentyFour Select Monthly Income Fund?

TwentyFour Select Monthly Income Fund (LON:SMIF) and Maven Income and Growth VCT 4 (LON:MAV4) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

15.1% of TwentyFour Select Monthly Income Fund shares are held by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are held by insiders. Comparatively, 1.8% of Maven Income and Growth VCT 4 shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Maven Income and Growth VCT 4 has lower revenue, but higher earnings than TwentyFour Select Monthly Income Fund. Maven Income and Growth VCT 4 is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TwentyFour Select Monthly Income Fund	£17.70M	18.12	N/A	£5.75	14.92
Maven Income and Growth VCT 4	-£111K	-727.01	£1.33M	-£0.34	N/A

In the previous week, TwentyFour Select Monthly Income Fund had 2 more articles in the media than Maven Income and Growth VCT 4. MarketBeat recorded 3 mentions for TwentyFour Select Monthly Income Fund and 1 mentions for Maven Income and Growth VCT 4. Maven Income and Growth VCT 4's average media sentiment score of 0.90 beat TwentyFour Select Monthly Income Fund's score of -0.19 indicating that Maven Income and Growth VCT 4 is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TwentyFour Select Monthly Income Fund	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Maven Income and Growth VCT 4	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TwentyFour Select Monthly Income Fund has a net margin of 57.51% compared to Maven Income and Growth VCT 4's net margin of 13.78%. TwentyFour Select Monthly Income Fund's return on equity of 5.95% beat Maven Income and Growth VCT 4's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TwentyFour Select Monthly Income Fund	57.51%	5.95%	N/A
Maven Income and Growth VCT 4	13.78%	-0.84%	-0.11%

TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.2%. Maven Income and Growth VCT 4 pays an annual dividend of GBX 4.35 per share and has a dividend yield of 9.0%. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Maven Income and Growth VCT 4 pays out -1,279.4% of its earnings in the form of a dividend. Maven Income and Growth VCT 4 is clearly the better dividend stock, given its higher yield and lower payout ratio.

TwentyFour Select Monthly Income Fund has a beta of 0.657, indicating that its share price is 34% less volatile than the broader market. Comparatively, Maven Income and Growth VCT 4 has a beta of 0.04891589, indicating that its share price is 95% less volatile than the broader market.

Summary

TwentyFour Select Monthly Income Fund beats Maven Income and Growth VCT 4 on 10 of the 14 factors compared between the two stocks.

How does Maven Income and Growth VCT 4 compare to The Biotech Growth Trust?

The Biotech Growth Trust (LON:BIOG) and Maven Income and Growth VCT 4 (LON:MAV4) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.

10.5% of The Biotech Growth Trust shares are owned by institutional investors. 1.5% of The Biotech Growth Trust shares are owned by company insiders. Comparatively, 1.8% of Maven Income and Growth VCT 4 shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Maven Income and Growth VCT 4 had 1 more articles in the media than The Biotech Growth Trust. MarketBeat recorded 1 mentions for Maven Income and Growth VCT 4 and 0 mentions for The Biotech Growth Trust. The Biotech Growth Trust's average media sentiment score of 1.63 beat Maven Income and Growth VCT 4's score of 0.90 indicating that The Biotech Growth Trust is being referred to more favorably in the media.

Company	Overall Sentiment
The Biotech Growth Trust	Very Positive
Maven Income and Growth VCT 4	Positive

The Biotech Growth Trust has higher revenue and earnings than Maven Income and Growth VCT 4. Maven Income and Growth VCT 4 is trading at a lower price-to-earnings ratio than The Biotech Growth Trust, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Biotech Growth Trust	£133.86M	2.25	£83.83M	£558.00	2.85
Maven Income and Growth VCT 4	-£111K	-727.01	£1.33M	-£0.34	N/A

The Biotech Growth Trust has a beta of 0.577, indicating that its stock price is 42% less volatile than the broader market. Comparatively, Maven Income and Growth VCT 4 has a beta of 0.04891589, indicating that its stock price is 95% less volatile than the broader market.

The Biotech Growth Trust has a net margin of 96.47% compared to Maven Income and Growth VCT 4's net margin of 13.78%. The Biotech Growth Trust's return on equity of 48.26% beat Maven Income and Growth VCT 4's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Biotech Growth Trust	96.47%	48.26%	12.39%
Maven Income and Growth VCT 4	13.78%	-0.84%	-0.11%

Summary

The Biotech Growth Trust beats Maven Income and Growth VCT 4 on 11 of the 13 factors compared between the two stocks.

Get Maven Income and Growth VCT 4 News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MAV4 vs. The Competition

Export

Metric	Maven Income and Growth VCT 4	Capital Markets Industry	Finance Sector	LON Exchange
Market Cap	£80.70M	£5.43B	£14.02B	£2.86B
Dividend Yield	4.33%	7.50%	5.94%	6.26%
P/E Ratio	-142.65	28.18	23.62	366.92
Price / Sales	-727.01	1,236.83	509.90	90,001.90
Price / Cash	3.07	47.91	40.57	27.89
Price / Book	0.77	3.51	2.74	6.33
Net Income	£1.33M	£417.39M	£1.31B	£5.89B
7 Day Performance	N/A	-1.80%	-1.19%	-0.75%
1 Month Performance	1.89%	-2.80%	-0.93%	-0.68%
1 Year Performance	-3.96%	3.70%	9.58%	19.29%

Maven Income and Growth VCT 4 Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MAV4 Maven Income and Growth VCT 4	N/A	GBX 48.50 flat	N/A	-5.7%	£80.70M	-£111K	N/A	N/A
BCI BMO Capital and Income Investment Trust	N/A	N/A	N/A	N/A	£324.01M	£29.78M	1,208.00	N/A	High Trading Volume
BPET BMO Private Equity Trust	N/A	N/A	N/A	N/A	£323.86M	£147.54M	248.86	N/A
BRFI BlackRock Frontiers	N/A	GBX 195 +1.6%	N/A	+13.7%	£322.25M	£81.92M	4.67	N/A	High Trading Volume
SMIF TwentyFour Select Monthly Income Fund	N/A	GBX 85.70 +0.4%	N/A	-2.3%	£320.40M	£17.70M	14.90	N/A	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:MAV4) was last updated on 9/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Maven Income and Growth VCT 4 (MAV4) Competitors

MAV4 vs. BCI, BPET, BRFI, SMIF, and BIOG

How does Maven Income and Growth VCT 4 compare to BMO Capital and Income Investment Trust?

Summary

How does Maven Income and Growth VCT 4 compare to BMO Private Equity Trust?

Summary

How does Maven Income and Growth VCT 4 compare to BlackRock Frontiers?

Summary

How does Maven Income and Growth VCT 4 compare to TwentyFour Select Monthly Income Fund?

Summary

How does Maven Income and Growth VCT 4 compare to The Biotech Growth Trust?

Summary

Media Sentiment Over Time

MAV4 vs. The Competition

Maven Income and Growth VCT 4 Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Maven Income and Growth VCT 4 (MAV4) Competitors

MAV4 vs. BCI, BPET, BRFI, SMIF, and BIOG

How does Maven Income and Growth VCT 4 compare to BMO Capital and Income Investment Trust?

Which has better valuation and earnings, BCI or MAV4?

Does the media prefer BCI or MAV4?

Is BCI or MAV4 a better dividend stock?

Is BCI or MAV4 more profitable?

Summary

How does Maven Income and Growth VCT 4 compare to BMO Private Equity Trust?

Is BPET or MAV4 more profitable?

Is BPET or MAV4 a better dividend stock?

Which has stronger earnings & valuation, BPET or MAV4?

Does the media prefer BPET or MAV4?

Summary

How does Maven Income and Growth VCT 4 compare to BlackRock Frontiers?

Do insiders & institutionals hold more shares of MAV4 or BRFI?

Which has more risk and volatility, MAV4 or BRFI?

Does the media prefer MAV4 or BRFI?

Is MAV4 or BRFI a better dividend stock?

Is MAV4 or BRFI more profitable?

Which has higher valuation and earnings, MAV4 or BRFI?

Summary

How does Maven Income and Growth VCT 4 compare to TwentyFour Select Monthly Income Fund?

Do institutionals & insiders believe in SMIF or MAV4?

Which has higher earnings & valuation, SMIF or MAV4?

Does the media refer more to SMIF or MAV4?

Is SMIF or MAV4 more profitable?

Is SMIF or MAV4 a better dividend stock?

Which has more volatility and risk, SMIF or MAV4?

Summary

How does Maven Income and Growth VCT 4 compare to The Biotech Growth Trust?

Do institutionals and insiders believe in BIOG or MAV4?

Does the media prefer BIOG or MAV4?

Which has stronger valuation and earnings, BIOG or MAV4?

Which has more risk and volatility, BIOG or MAV4?

Is BIOG or MAV4 more profitable?

Summary

Media Sentiment Over Time

MAV4 vs. The Competition

Maven Income and Growth VCT 4 Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools